LUM and melanoma: Lumican overexpression decreases subcutaneous primary melanoma tumor growth in vivo, with a concomitant decrease of cyclin D1 expression (Vuillermoz et al., 2004) as well as a decrease in the number of lung metastatic nodules in which an increase of tumor cell apoptosis was observed.